What the ‘IPO lite’ SEC rule change means for life sciences startups, crowdfunding and venture capital
A new SEC rule change will allow startups to crowdfund for much, much larger sums of money. What does this mean for the life sciences industry? Consider this scenario: You’re an early stage biotech, in an orphan field that has an active and passionate patient advocacy base. They aren’t wealthy, but they’re willing to invest. A handful […]